COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

COST

1,048.96

+0.89%↑

80.84

+0.46%↑

141.6

-0.8%↓

189.84

-1.05%↓

PEP

149.1

+0.33%↑

Home・Aktien・Afya Ltd (Class A)

Afya Ltd (Class A)

Geschlossen

BrancheKonsumgüter defensiv

13.92 1.16

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

13.82

Max

13.96

Schlüsselkennzahlen
By Trading Economics
Einkommen	77M 252M
Verkäufe	67M 994M
KGV Branchendurchschnitt	8.389 25.889
EPS	2.85
Dividendenrendite	4.69
Gewinnspanne	25.379
Angestellte	9,395
EBITDA	200M 477M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+37.8% upside

Dividenden
By Dow Jones
Dividendenrendite Branchendurchschnitt	4.69% 3.64%
Nächstes Ergebnis	13. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	2.7M 1.3B
Vorheriger Eröffnungskurs	12.76
Vorheriger Schlusskurs	13.92

Nachrichtenstimmung

By Acuity

34%

66%

24 / 131 Ranking in Consumer defensive

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

18.968 / 19.56 Unterstützung & Widerstand

Afya Ltd (Class A) Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Afya Ltd (Class A) Prognose

Kursziel

By TipRanks

37.8% Vorteil

12-Monats-Prognose

Durchschnitt 19.25 USD 37.8%

Hoch 21.5 USD

Tief 17 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Afya Ltd (Class A) – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Afya Ltd (Class A) – Dist abgegeben haben.

Technischer Score

By Trading Central

18.968 / 19.56Unterstützung & Widerstand

Recent bullish events outweigh bearish events.

All events are bullish.

Stimmung

By Acuity

24 / 131 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.